Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Video vs Telephone Consultations for Pediatric Quality of Care in Emergency Departments.

Pediatrics·2026
Same author

Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's disease.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Addressing inequities in maternal health through postpartum nurse home visiting: a mixed methods evaluation.

BMC pregnancy and childbirth·2026
Same author

Editorial: Advancements in mental health services: elucidated promising new paths along which to seek answers to improve our mental health systems.

Frontiers in health services·2026
Same author

Standard Versus Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): Protocol for a Cluster Randomized Implementation-Effectiveness Trial.

Cureus·2025
Same author

Associations of cumulative hearing and vision loss with depression among U.S. adults aged 50 and older: results from the health and retirement study.

BMC psychiatry·2025

Related Experiment Video

Updated: Sep 4, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K

Analyzing a Cost-Effectiveness Dataset: A Speech and Language Example for Clinicians.

Jeffrey S Hoch1,2, Sarah C Haynes3,4, Shannon M Hearney1

  • 1Division of Health Policy and Management, Department of Public Health Sciences, University of California, Davis, California.

Seminars in Speech and Language
|July 20, 2022
PubMed
Summary

Cost-effectiveness analysis (CEA) evaluates new treatments by comparing outcomes to costs. This study demonstrates using net benefit regression for analyzing CEA data, advocating for more person-level analyses to prove treatment value.

More Related Videos

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.9K
A Low Cost Setup for Behavioral Audiometry in Rodents
09:23

A Low Cost Setup for Behavioral Audiometry in Rodents

Published on: October 16, 2012

12.8K

Related Experiment Videos

Last Updated: Sep 4, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
12:43

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

34.9K
A Low Cost Setup for Behavioral Audiometry in Rodents
09:23

A Low Cost Setup for Behavioral Audiometry in Rodents

Published on: October 16, 2012

12.8K

Area of Science:

  • Health Economics
  • Clinical Research Methodology

Background:

  • Cost-effectiveness analysis (CEA) is vital for healthcare resource allocation.
  • Funding for new treatments relies on demonstrating value for money.
  • Existing methods for analyzing CEA data can be complex.

Purpose of the Study:

  • To present a clear framework for analyzing cost-effectiveness datasets.
  • To demonstrate the application of net benefit regression in CEA.
  • To encourage the use of person-level data in economic evaluations.

Main Methods:

  • Utilized a hypothetical dataset to illustrate the analysis process.
  • Employed net benefit regression as the analytical framework.
  • Visualized results using standard cost-effectiveness graphs.

Main Results:

  • Demonstrated the creation of estimates and uncertainty characterization.
  • Provided clear explanations of analytical outputs.
  • Showcased practical application through a hypothetical case.

Conclusions:

  • Net benefit regression offers a robust method for cost-effectiveness analysis.
  • Person-level analysis is crucial for generating credible evidence on treatment value.
  • Further adoption of these methods will enhance healthcare decision-making.